Patients with sinus and nasal disorders whose symptoms persist despite primary care may benefit fro m a referral to a dedicated nose and sinus center where all treatm ent modalities are availabl e. The esse ntial prin ciple of a multimodality approach is that medical therapy, allergy treatm ent , and surgery are all imp ortant and useful tools. While various medical and surgical treatm ents of sinus and nasal disorders have been well described in the literature, overall assessments of comp rehensive treatm ent are uncommon. For more than 7 years, the office pra ctice of the senior autho r (D. G.B.) has been dedicated to the treatment ofsinus and nasal disorders. In an effo rt to assess the results ofthe niultim odality appro ach to therapy delivered there, we mail ed questionnaires to 1,800 pati ents who had been treated at this p ractice over a 3-year period. Responsesjrom 222 of these pati ents revea led that pa tients required less medicat ion f ollowin g treatm ent with a multimodality approach and that they exp ressed a high degree ofsatisfaction with the comprehens ive care they received. In addition, most patients with asthm a experienced relief of their asthm a symp toms fo llowing treatment for sinonasal disease. We conclude that a stepwise, multimodality, specialty-cellter app roach to treatm ent is beneficial f or patients with persistent sinonasal diso rde rs.
Introduction
Until recently, sinusitis has been an undertreated disease. Its drastic negativ e effect on quality of life has been generall y underapp reci ated . Some studies have show n that patients may consid er certain consequ ences of chronic sinus disease, such as bod ily pain and impa ired social functi onin g, to be mor e debilitatin g than angina, co ngestive heart failure , emphyse ma, chronic bron chiti s, lower back pain, and other diseases and conditions.P Both nasal and oral agent s ca n be used to treat patients with nasal symptoms and muc osal disease. Typi cal age nts includ e steroids, saline sprays, mucol ytic s, antihi stamines, decongestant s, and antibi otics. When inhalant allergies are a significa nt contributory factor, immunotherapy is an option. To date, no standardized, uni versall y accepted treatment protocol that constitutes "max imum medical therapy" has been developed. Th e selection of the appropriate medic ation depend s on the specific diagno sis and vari es from patient to patient.
Surgical inter vention for sinusitis is co nsidered when medical management fails to relieve sy mpto ms. Functional endoscopic sinus surger y (FESS) has become the most widely accepted approach for patient s who require surgical managem ent of sinusitis. Th e goa l of surgery is to return the sinuses to as near a normal anatomic state as is possible and to correc t conditions that impede mucocili ary clearance, especially throu gh the ostiom eatal complex.The use of powered instrumentation (i.e., mic rodebrider s and soft-tissue shaver s) during FESS offers several potenti al advantages, including less traum a and bleeding, shorter surgical time , more rapid healin g, and a better overall recovery?"
Comput er-assisted surgery, also know n as image-guided surgery, was initi ally developed in an effort to imp rove the accura cy of localizing lesions, anatomic landm arks, and surgical instruments durin g neurosurgical procedu res.v'? In the paranasal sinuses , the surgeo n is usually able to locali ze the tip of a surgical instrument to within 2 mm on coron al, axial, and sagittal computed tomograph y (CT) . Computer-assisted FESS may be most useful in cases where surgical landmarks have been altered by previous surge ry, dense scarring, or extensive disease.
Patients with sinus and nasal disord ers whose symp- 
Patients and methods
We sea rched a database that included the record s of all patients who had been see n by the sen ior author from Janu ary 1999 through Decemb er 200 I. We mailed a6-page questio nnaire and a postage-p aid return envelope to 1,800 of these patients, and we rece ived 247 repli es (13.7 %). Of the 247 respondents, 25 had been see n for purely nonsinus issues, leaving us with 222 usable replies. Patient s were asked to list the functio nal probl em s for which they had sought treatm ent and to indicate whether their definitive treatment had been medical or surgical or if they had required a combination of both to ac hieve a cure. Th ey were also asked to se lect from a list of medications those that they had used both before and after they rece ived treatment and to rate the effectiveness of eac h medi cation on a sca le Medication of I (co mpletely ineffec tive) to 10 (co mpletely effec tive).
Oxymetazoline In addition, respondents who Antibiotic had been di agn osed with asth ma were aske d whether Azelastine treatm ent of their sinonasa l pathology had helped relieve Oral decong estant their asthma sympto ms. Finall y, all patient s were aske d Mucolytic to rate the overall effec tiveness oftreatment in reliev ing Oral predn isone sinonasa l sy mptoms on the same rating sca le.
Saline irrigation tom s persist despite sta ndard office care -particularly by primary care physicians-may benefit fro m a referral to a ded icated nose and sinus ce nter where all treatment modalitie s are ava ilable. The essential principle of a multimodality approach to sin usitis is that medical therapy, allergy treatm ent , and surgical therapy are all impor tant and useful tools. For more than 7 yea rs, the office practice of the senior author(D.G.B.) has been dedicated to the treatment of sinus and nasal disord ers. In an effo rt to assess the res ults of the stepwise, mult imodality app roac h to therapy delivered there, we mailed questionnaires to a large gro up of patient s who had been trea ted at this practice over a 3-year period. In this article, we describ e the result s of our survey. Based on a scale of 1 (comp letely ineffe ctive) To 10 (co mp letely effe clive). Some patients did not answer all sllJ"l'ey questions .
prior to therapy, the most co mmonly used dru gs followin g treatment were nasal steroid sprays (110 patients [49.5%D, oral antihistamines (8 1 [36.5%D, and nasal saline sprays (73 [32.9%D.
Medication effe ctiveness. On the IO-point scale, patients rated oral predni sone (mean score: 7.91) and antibiotics (mean: 7.83) as the most effec tive dru gs (table 3) . Th e lowest mean scores were give n to aze lasti ne (5.00), oral decongestant s (5.97), mont elukast (6. 13), and nasal saline sprays (6.17).
Asthma. Thi rty-five patient s ( 15.8%) reported that they had asthma-12 in the med ical 0TO UP 9 in the surzical Overall treatm ent eff ectiveness. A total of 165 patients had responded to medical therapy, either alone (n =99) or in combination with surgery (n =66) (medical/co mbined group). Of this group, 144 rated the overall effec tive ness of medical treatment. Likewise, 123 patient s had respo nded to surge ry alone (n = 57) or in combination with medical treatm ent (n = 66) (surgical/co mbined gro up), and 114 of them rated the overall effec tive ness of surgery. On the 10-point scale, the mean effective ness score for medical therapy was 7.19 and the mean score for surge ry was 7.96; the overall score was 7.53 (table 5). No patient indicated that symptoms wo rsened afte r treatm ent. Among the 144 res pondents in the medical/comb ined group, 109 (75.7%) rated the effectiveness oftheir treatment with a score of 6 or more. In the surg ical/combined group , a rating of 6 or more was given by 96 of 114 respondent s (84 .2%). Overall, a rating of 6 or more was give n by 205 of the 258 respond ent s (79.5%), and a rating of 5 or more by 222 (86.0 %).
Discussion
The data collected from these questionnaires warrant critical analysis. Most notable are the percent age of patients who res ponded to medical therapy alone and the percentages who required surgery or combined therapy.
Medical therapy. Careful, directed sinus and nasal histories and physical examinations allowe d the se nior author to develop a tailored medic al regimen that was successful in 99 of the 222 patient s (44.6 %). Th ese patient s, the vast majority of whom had been previously treated by prim ary care physician s, required no further therap y.
Surgical therapy. When symptoms could not be controlled by medical ther apy alone, surgical interve ntion was undertaken when appropriate. Fifty-seven of the 222 patients (25.7%) who did not improve adequately with medical treatment were successfully treated with subsequent surgery. The data presented here suggest that correc tion of fixed struc tural blockage had a posit ive effec t on symptoms, as evide nced by not only patients' posi tive evaluat ions of treatment, but by their decreased need for posttrea tmen t medication.
Combined therapy. Sixty-six patients (29.7 %) requi red both medical and surgical treatment for significant symptom relief. Th is highlights the effectiveness of a stepw ise, multimodality approach in which all aspec ts of a patient's sinus and nasal prob lem are eva luated at a specia lty center.
Medication use. Most patients treated for sinonasal disease had used some form of intra nasa l or ora l medication. The most common were nasal steroid sprays (e.g., f1uticasone and triamci nolone), oral antihistam ines, nasa l saline sprays, antibiotics, and oral decongestants; others included oxymetazoline, mucolytics, sali ne irrigat ions, ora l prednisone, azelastine, and montelukast. Our survey revealed a posttreat ment decrease in the use of every type of medication listed. There are specific areas where the senior author believes his co ncerted effor ts led to a decrease in the need for certain medicatio ns. For insta nce, the senior author urges pat ients to reduce their use of oral decongestants as a routine medication because of the risk of chro nic syste mic vasoconstriction; the use of oral deco nges tants, which had been take n by 103 patients (46.4 %), decl ined by 68.9%. Also, the routine use of nasal decongestant sprays is strongly discouraged because overuse leads to rhinitis medicament osa; the need for oxymetazoli ne, which had been used by 6 1 patients (27.5%) prior to treatment , decreased by 78.7 % posttreatment. The fair ly co mmo n use of oxymetazoli ne prior to treatment may be attribu table to its quick onset of action, its efficacy over the first few days of use, and its over-the-cou nter avai lability; in addition, it is reaso nable to ass ume that some percentage of these patients were chronic users who were "hooked" on oxy metazo line as a result of its tendency to cause rebound rhinitis when used for more than a few days . The fact that large percentages of patient s discontinued ora l and nasal decongestants sugges ts that the senior author's approac h was successful.
The senior author also routine ly informs patien ts that the proph ylactic use of nasal steroi d sprays , nasal saline sprays , antihis tamines, muco lytics , and other adju nctive medica tions can decrease the risk of infec tions and thereby lessen the need for antibiotics. Indeed, the use of antibiotics by 112 of the 222 patient s (50.5 %) decli ned by 76.8 % posttreatment. Some patients may need to take these adjunctive medica tions at the first signs of symptoms, while others may need to follow a tailored daily medical regime n. The three most commonly used pretreatme nt agents -nasal steroid sprays, ora l antihis tamines, and nasa l saline sprays-remained the most freque ntly used substa nces follow ing treatment. The cont inued use of Volume 85, Number 1 these agents may be attributable to their relative efficacy and safe ty. We infer from our data that regardless of treatment modality, nasal steroi ds, ora l antihistamines, and nasal saline spray s play an important role in maintaining control of sino nasa l disease after medical, surgical, or com bined treatment.
Medication ef fec tiveness. It was quite revealing that patients rated ora l prednisone and antibiotics as the mos t effec tive drugs (mea n scores : 7.9 1and 7.83 , respectively). We can specu late that these age nts "worked the best " because they are typically used in the setting of an acute exacerbation of symptoms; it is understandable that patients wou ld highly regard an age nt that effects a timely resol ution of an acute episode.
It is also interesting to note that whi le nasal saline sprays were one of the most co mmo nly used agents pre-and posttherapy, they received one of the lowest effectiveness ratings (6. 17). Possi ble reaso ns for the low rating include the facts that nasal saline sprays ( I) are typically used as a maintenance therapy, (2) are rarely used as a monotherapy, and (3) typically offer little subjec tive relief during an acute episode. Even so, the numerous ben efits of nasal saline sprays (e.g., loosening nasal secretions and improving the mucosal penetratio n of nasal steroid sprays) should not be overlooke d by phys icians, eve n if they are not apparent to patie nts. Ora l decongestants received the second-lowes t effectiveness score (5.97), possi bly because of their side effects (e.g., increased heart rate and jitteriness).
Asthma. The subjective improveme nt in asthma sta tus reported by 21 of the 35 asthmatics (60.0 %) was fairly cons istent regard less of the type of trea tment. Although improvement was not based on meas urements such as pulmo nary function tests, it is nevertheless consistent wit h reports of other studies in which control ofsinonasal disease resulted in an improvement in asthma status. I 1-13 Study limitations. A few limitation s attended to our questionnaire and subseq uent evaluation of data. Patients were not asked to specify the total .length of time they had used eac h medication, the daily dosing regime n, or the subtype of medication (e.g., sedati ng or nonsedating antihista mine or the specific class of antibiotic, etc.) . Our analysis might have revea led slightly differe nt trend s had these factors been acco unted for. However, the objec tive of our survey was to assess general tre nds with regard to the care rendered at the senior author's practice. Those trends reflected a high degree of patient satisfaction, as 75 .7% of medically treated patien ts and 84.2% of surgically treated patients rated their care as a 6 or more on the 10-point scale. No patient indica ted that symptoms were worse after treatment.
Finally, it is importa nt to point ou t that the patie nts in this study were see n by the senio r author at a tertiary care center. Prior to those enco unters, a sig nificant number of these patients had undergone spec ialty evaluatio n and malignant cartilaginou s tumor s.v" Long-term follow-up of a benign chondroma is neces sary bec ause ofthe possibility that malignant tran sformation will occur," treatment, including sinu s surgery, elsewh ere. It is possible that their problem s were more severe than tho se seen in a community practice, yet their degree of satisfaction with comprehensiv e, multi modality, specialty-cent er appro ach to sinonasal disease was high .
